Brief: Nemaura Medical reports Q1 2023 results
Aug 15 (Reuters) - Nemaura Medical Inc NMRD.O :
* NEMAURA MEDICAL REPORTS FISCAL FIRST QUARTER 2023 RESULTS
AND
PROVIDES BUSINESS UPDATE
* NEMAURA MEDICAL INC - CASH AND CASH EQUIVALENTS AT JUNE
30, 2022
WERE APPROXIMATELY $14.8 MILLION, AS COMPARED TO $17.7 MILLION
AT MARCH 31, 2022
* NEMAURA MEDICAL INC - QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED $0.17
Source text for Eikon: ID:nGNX4mJZqb
Further company coverage: NMRD.O
Recent news on Nemaura Medical
See all newsBrief: Nemaura Medical To Move To OTC Markets
U.S. RESEARCH ROUNDUP- Ameren Corp, Bread Financial Holdings, Exelon Corp
Brief: Nemaura Medical Receives Positive Nasdaq Listing Decision
Brief: Nemaura Medical Secures $10 Mln Non-Dilutive Credit Facility
Brief: Nemaura Launches Direct To Consumer Offering Of Metabolic Health Program